Kaiser Permanente workers strike for second day after negotiations fail to reach labor contract

Kaiser Permanente workers strike for second day after negotiations fail to reach labor contract


Kaiser Permanente employees, joined by Union members representing the workers, walk the picket line in Los Angeles, California on October 4, 2023. 

Frederic J. Brown | AFP | Getty Images

Tens of thousands of Kaiser Permanente workers remained on strike for a second day after negotiators failed to reach an agreement to end a dispute over a short-staffing crisis at health facilities.

A spokesperson for the Coalition of Kaiser Permanente Unions, said that the strike — said to be the largest health-care worker walkout in U.S. history — will continue until Saturday morning at the latest as the group waits for “a meaningful response from Kaiser executives” to its demands.

There are currently no bargaining sessions scheduled with Kaiser, said the spokesperson, Caroline Lucas.

More than 75,000 workers went on strike Wednesday at hundreds of Kaiser Permanente health facilities in California, Colorado, the District of Columbia, Oregon, Virginia and Washington state.

Nearly 60,000 of those workers are in California.

Kaiser Permanente workers in D.C. and Virginia struck for one day and returned to work Thursday, but will continue in the other four states through Saturday morning “barring any dramatic action from Kaiser executives to address the short staffing crisis,” Lucas said.

CNBC Health & Science

Read CNBC’s latest health coverage:

Operations, chemotherapy treatments and other “non-urgent” procedures were postponed Wednesday due to the strike, NBC News reported.

Kaiser Permanente has said all hospitals and emergency departments will remain open during the work stoppage, but elective procedures may have to be postponed.

Kaiser Permanente is the largest private, nonprofit health-care organization in the U.S.

It serves nearly 13 million patients and operates 39 hospitals and more than 600 medical offices across eight states and D.C.



Source

Abbott stock fell victim to an old earnings season truth: It’s all about the guidance
Health

Abbott stock fell victim to an old earnings season truth: It’s all about the guidance

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus estimate, according to estimates compiled by LSEG. Organic sales , excluding Covid testing results, […]

Read More
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Health

Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount

Bristol Myers Squibb and Pfizer on Thursday said they will start selling their blockbuster blood thinner, Eliquis, directly to patients at a more than 40% discount. The move comes as the Trump administration ramps up pressure on the pharmaceutical industry to cut drug prices, and threatens to impose sweeping tariffs on pharmaceuticals imported into the […]

Read More
Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise
Health

Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise

Boxes of tablets, produced by Novartis AG, sit on a pharmacy counter. Bloomberg | Bloomberg | Getty Images Swiss pharmaceutical firm Novartis said Thursday that it expects its Kisqali breast cancer treatment to be the next blockbuster drug within its portfolio, as it looks to shift reliance away from its Entresto heart failure therapy. Sales of Kisqali, […]

Read More